Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Chubb
Express Scripts
Merck
McKinsey
Healthtrust
US Department of Justice
Dow

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,906,898

« Back to Dashboard

Which drugs does patent 8,906,898 protect, and when does it expire?

Patent 8,906,898 protects ZERBAXA and is included in one NDA.

This patent has eight patent family members in six countries.
Summary for Patent: 8,906,898
Title:Solid forms of ceftolozane
Abstract: Novel solid forms of ceftolozane are described, as well as methods for the preparation and use of these solid forms.
Inventor(s): Hwang; You Seok (Windham, NH), Damour; Nicole Miller (Belmont, MA), Duong; Lisa (Lynn, MA), Jurkauskas; Valdas (Cambridge, MA), Moshos; Kristos Adrian (Belmont, MA), Mudur; Sanjay (Woburn, MA), Ovat; Asli (Maynard, MA), Terracciano; Joseph (Concord, MA), Woertink; Jason (Sudbury, MA)
Assignee: Calixa Therapeutics, Inc. (Lexington, MA)
Application Number:14/289,224
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation;

Drugs Protected by US Patent 8,906,898

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Cubist Pharms Llc ZERBAXA ceftolozane sulfate; tazobactam sodium POWDER;IV (INFUSION) 206829-001 Dec 19, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,906,898

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014233633 ➤ Sign Up
Australia 2016200570 ➤ Sign Up
European Patent Office 3049079 ➤ Sign Up
Mexico 2016003958 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Department of Justice
US Army
Chinese Patent Office
Harvard Business School
Cantor Fitzgerald
Boehringer Ingelheim
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.